Caterna Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Caterna General Information

Description

Operator of an online digital therapy platform designed to provide a supplement to occlusion therapy for children with amblyopia or lazy eye. The company's platform offers web-based exercises for the treatment of neurological defect vision which are combined with online games for attention-grabbing in the screen foreground, enabling patients to stimulate the brain to re-establish the connection between the brain and eye.

Contact Information

Website
www.caterna.de
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • David-Gilly-Strasse 1
  • 14469 Potsdam
  • Germany
+49 0331
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • David-Gilly-Strasse 1
  • 14469 Potsdam
  • Germany
+49 0331

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caterna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC 24-Jul-2017 Completed Generating Revenue
7. Early Stage VC (Series A) 01-May-2014 Completed Generating Revenue
6. Grant 04-Jun-2013 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
4. Bankruptcy: Admin/Reorg 01-Jan-2012 Completed Bankruptcy: Admin/Reorg
3. Early Stage VC 14-Jan-2011 Completed Startup
2. Grant 01-Jan-2010 $29K Completed Startup
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Caterna’s complete valuation and funding history, request access »

Caterna Patents

Caterna Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160271001-A1 Method and apparatus for the treatment of amblyopia Active 20-Mar-2015
US-9597253-B2 Method and apparatus for the treatment of amblyopia Active 20-Mar-2015
DE-202014001153-U1 Digital occlusion diary with reminder function to support ocular patch treatment for amblyopia Inactive 07-Feb-2014
DE-102011119361-A1 Method and device for improving the visual performance Active 23-Nov-2011
DE-102011119361-B4 Visual performance enhancer and method for generating attention-grabbing stimuli on a display element Inactive 23-Nov-2011 A61H5/00
To view Caterna’s complete patent history, request access »

Caterna Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Caterna Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandenburg Kapital Venture Capital Minority
Investitionsbank des Landes Brandenburg Investment Bank Minority
Peppermint Venture Partners Venture Capital Minority
Flying Health Accelerator/Incubator Minority
Science4Life Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Caterna FAQs

  • When was Caterna founded?

    Caterna was founded in 2010.

  • Where is Caterna headquartered?

    Caterna is headquartered in Potsdam, Germany.

  • What is the size of Caterna?

    Caterna has 9 total employees.

  • What industry is Caterna in?

    Caterna’s primary industry is Clinics/Outpatient Services.

  • Is Caterna a private or public company?

    Caterna is a Private company.

  • What is Caterna’s current revenue?

    The current revenue for Caterna is .

  • How much funding has Caterna raised over time?

    Caterna has raised $855K.

  • Who are Caterna’s investors?

    Brandenburg Kapital, Investitionsbank des Landes Brandenburg, Peppermint Venture Partners, Flying Health, and Science4Life are 5 of 6 investors who have invested in Caterna.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »